XOMA Royalty Corp
XOMA26.960USD
+0.850+3.26%
收盘 07/03, 13:00（美东）报价延迟15分钟
322.25M总市值
亏损市盈率 TTM
关于 XOMA Royalty Corp 公司
XOMA Royalty Corporation 是一家生物技术专利费整合商。该公司的专利费整合业务主要专注于早期至中期临床资产，主要处于 I 期和 II 期，具有巨大的商业销售潜力，并已授权给大型制药合作伙伴。该公司拥有与合作的商业和商业前治疗候选药物相关的一系列经济权利和专利费支付。该公司的特许权使用费组合包括 OJEMDA (tovorafenib)、JNJ-63723283 (cetrelimab)、RZ358、arimoclomol、mezagitamab (TAK-079)、acimtamig (AFM13)、AB054、ficlatuzumab (AV-299)、COM902、vosaroxin、aldoxorubicin、 INCAGN02385、INCAGN02390、MNPR-101、PBF-680、PBF-677、PBF-999、PBF-1129、PBF-1650、RZ402、DSUVIA（舒芬太尼舌下片）、IXINITY [凝血因子 IX（重组）]、CMP-001（维多莫德）、 NTM-1631、NTM-1634、 NTM-1633、NTM-1632、NIR178、MK-4830、AFM24、INCAGN01949、AB101 和 CFZ533（iscalimab）。
公司简介
公司代码XOMA
公司名称XOMA Royalty Corp
上市日期Jun 06, 1986
成立日期2011
CEOMr. Owen P. Hughes, Jr.
员工数量13
证券类型Ordinary Share
年结日Jun 06
公司地址2200 Powell Street
城市EMERYVILLE
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编94608
电话15102047239
网址https://www.xoma.com/
公司代码XOMA
上市日期Jun 06, 1986
成立日期2011
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Jack L. Wyszomierski
Mr. Jack L. Wyszomierski
Independent Chairman of the Board
Independent Chairman of the Board
12.44K
+92.36%
Mr. Joseph M. (Joe) Limber
Mr. Joseph M. (Joe) Limber
Independent Director
Independent Director
6.21K
-0.03%
Ms. Natasha A. Hernday
Ms. Natasha A. Hernday
Independent Director
Independent Director
5.97K
--
Ms. Heather L. Franklin
Ms. Heather L. Franklin
Independent Director
Independent Director
5.97K
--
Mr. Thomas (Tom) Burns
Mr. Thomas (Tom) Burns
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Ms. Barbara A. Kosacz, J.D.
Ms. Barbara A. Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Matthew D. Perry
Mr. Matthew D. Perry
Independent Director
Independent Director
--
--
Mr. Owen P. Hughes, Jr.
Mr. Owen P. Hughes, Jr.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Bradley J. (Brad) Sitko
Mr. Bradley J. (Brad) Sitko
Chief Investment Officer
Chief Investment Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Jack L. Wyszomierski
Mr. Jack L. Wyszomierski
Independent Chairman of the Board
Independent Chairman of the Board
12.44K
+92.36%
Mr. Joseph M. (Joe) Limber
Mr. Joseph M. (Joe) Limber
Independent Director
Independent Director
6.21K
-0.03%
Ms. Natasha A. Hernday
Ms. Natasha A. Hernday
Independent Director
Independent Director
5.97K
--
Ms. Heather L. Franklin
Ms. Heather L. Franklin
Independent Director
Independent Director
5.97K
--
Mr. Thomas (Tom) Burns
Mr. Thomas (Tom) Burns
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Ms. Barbara A. Kosacz, J.D.
Ms. Barbara A. Kosacz, J.D.
Independent Director
Independent Director
--
--
收入明细
单位: USD更新时间: 7月2日 周三
单位: USD更新时间: 7月2日 周三
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
暂无数据
地区USD
名称
营收
占比
United States
6.09M
38.30%
Switzerland
5.82M
36.56%
Asia Pacific
4.00M
25.14%
业务
地区
暂无数据
股东统计
更新时间: 5月22日 周四
更新时间: 5月22日 周四
持股股东
股东类型
持股股东
持股股东
占比
BVF Partners L.P.
21.65%
Morgan Stanley Investment Management Inc. (US)
9.23%
Fidelity Management & Research Company LLC
8.68%
BlackRock Institutional Trust Company, N.A.
4.10%
The Vanguard Group, Inc.
3.84%
Other
52.51%
持股股东
持股股东
占比
BVF Partners L.P.
21.65%
Morgan Stanley Investment Management Inc. (US)
9.23%
Fidelity Management & Research Company LLC
8.68%
BlackRock Institutional Trust Company, N.A.
4.10%
The Vanguard Group, Inc.
3.84%
Other
52.51%
股东类型
持股股东
占比
Hedge Fund
26.12%
Investment Advisor/Hedge Fund
18.89%
Investment Advisor
17.15%
Individual Investor
1.34%
Research Firm
0.34%
Pension Fund
0.08%
Bank and Trust
0.07%
Insurance Company
0.02%
Other
35.99%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
147
7.66M
64.02%
+67.58K
2025Q1
150
7.99M
66.81%
+297.02K
2024Q4
151
7.96M
67.53%
-445.61K
2024Q3
149
7.79M
66.29%
-572.80K
2024Q2
143
7.78M
66.74%
-664.29K
2024Q1
144
7.71M
66.30%
-615.38K
2023Q4
149
7.62M
66.29%
-820.22K
2023Q3
146
7.80M
68.02%
-670.64K
2023Q2
148
7.93M
69.11%
+32.68K
2023Q1
155
7.51M
65.57%
+97.45K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BVF Partners L.P.
2.59M
21.65%
-392.72K
-13.17%
May 16, 2025
Morgan Stanley Investment Management Inc. (US)
1.10M
9.23%
+811.40K
+277.18%
Mar 31, 2025
Fidelity Management & Research Company LLC
1.04M
8.68%
-1.68K
-0.16%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
490.59K
4.1%
-8.20K
-1.64%
Mar 31, 2025
The Vanguard Group, Inc.
459.09K
3.84%
-4.75K
-1.02%
Mar 31, 2025
Opaleye Management Inc.
253.04K
2.11%
+3.04K
+1.22%
Mar 31, 2025
Geode Capital Management, L.L.C.
186.67K
1.56%
+4.48K
+2.46%
Mar 31, 2025
Woodline Partners LP
168.55K
1.41%
+12.28K
+7.86%
Mar 31, 2025
State Street Global Advisors (US)
144.73K
1.21%
+200.00
+0.14%
Mar 31, 2025
Stonepine Capital Management, LLC
129.81K
1.08%
+4.11K
+3.27%
Mar 31, 2025
查看更多
持股ETF
更新时间: 7月2日 周三
更新时间: 7月2日 周三
机构名称
占比
iShares Micro-Cap ETF
0.04%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
查看更多
iShares Micro-Cap ETF
占比0.04%
ProShares Hedge Replication ETF
占比0.01%
iShares Russell 2000 ETF
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
iShares Russell 2000 Value ETF
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
Global X Russell 2000 ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
Avantis US Equity ETF
占比0%
Avantis US Small Cap Equity ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
